Evaluation of Multi-drug Integrated Minimum Alveolar Concentration (iMAC) During Propofol/Remifentanil Anesthesia

• Status: Not yet recruiting
• Trial end date: 2024-03-01
• Target enrollment: 0
• Participant gender: All

Summary

The aim of this study is to verify the accuracy of iMAC compared to Bispectral Index (BIS) for depth and nociceptive stimulation monitoring of anesthesia during general anesthesia.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Zhang Haopeng
• Treatments: Propofol; Remifentanil

Criteria

Inclusion Criteria:

1. Patients undergoing elective surgery under general anesthesia;

2. Patients with ASA rating I~III;

3. The age of the patient is more than 18 years old;

4. The informed consent has been signed;

Exclusion Criteria:

1. Patients who are participating in other trials;

2. Patients with cognitive impairment, mental illness or taking psychotropic drugs within three months;

3. Patients with a history of stroke;

4. Patients with a history of alcoholism (long-term drinking more than 5 years, daily white wine consumption ≥ 50ml);

5. Pregnant women;

6. Patients with BMI>30;

7. Patients and family members who are unwilling to participate after understanding the research content;

8. According to the evaluation of the researcher, the actual condition is not suitable for the patients participating in this trial.